Mr. Speaker, I wish the minister had had the courage to answer himself. It is his choice to answer through his parliamentary secretary, but I will carry on just the same.
An American patient was fitted with Mentor silicone gel implants during a breast augmentation surgery in 2000. We are not talking about the 1960s, the 1970s or the 1980s; we are talking about the year 2000. Sometime during the year, the patient developed a Staphylococcus aureus infection. The same year, the implants had to be removed, and a few weeks later, the patient died from septic shock and multiple organ failure.
How can the minister have allowed the reintroduction of breast implants instead of making the regulations governing the special access program stricter and waiting until sufficient data had—